Literature DB >> 7067758

Pulmonary function in moderate neuromuscular disease without respiratory complaints.

M Demedts, J Beckers, F Rochette, J Bulcke.   

Abstract

Pulmonary function studies were carried out in 29 patients with moderate neuromuscular disease who had virtually no respiratory complaints. The earliest and most pronounced abnormalities were decreased transrespiratory pressures. Next a restrictive pulmonary defect with increased residual volume and a proportional decrease of maximal expiratory flows occurred, together with a decrease in static lung compliance. Because of a decrease in transpulmonary pressure at total lung capacity and often an increase in diffusing capacity per unit lung volume the above mentioned restrictive defects were attributed to muscular weakness and interstitial lung disease was excluded. Finally, some ventilation inequality could be found, probably originating in the poorly ventilated supradiaphragmatic regions.

Entities:  

Mesh:

Year:  1982        PMID: 7067758

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  4 in total

Review 1.  Measurement of respiratory muscle strength.

Authors:  M I Polkey; M Green; J Moxham
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

2.  Control of breathing in patients with limb girdle dystrophy: a controlled study.

Authors:  F Gigliotti; A Pizzi; R Duranti; M Gorini; I Iandelli; G Scano
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

3.  Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis.

Authors:  P Goti; A Spinelli; G Marconi; R Duranti; F Gigliotti; A Pizzi; G Scano
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

4.  Randomized trial of lung hyperinflation therapy in children with congenital muscular dystrophy.

Authors:  Hemant Sawnani; Oscar H Mayer; Avani C Modi; John E Pascoe; Keith McConnell; Joseph M McDonough; Anne M Rutkowski; Md Monir Hossain; Rhonda Szczesniak; Dawit G Tadesse; Christine L Schuler; Raouf Amin
Journal:  Pediatr Pulmonol       Date:  2020-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.